Fenretinide LXS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fenretinide LXS, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma [Phase 1]